Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

PredictABEL: an R package for the assessment of risk prediction models

A Medical Bioinformatics Approach for Metabolic Disorders: Biomedical Data Prediction, Modeling, and Systematic Analysis

Genal: A Python Toolkit for Genetic Risk Scoring and Mendelian Randomization

A Non-Parametric Method for Building Predictive Genetic Tests on High-Dimensional Data

hibayes: An R Package to Fit Individual-Level, Summary-Level and Single-Step Bayesian Regression Models for Genomic Prediction and Genome-Wide Association Studies

GAPIT Version 2: an Enhanced Integrated Tool for Genomic Association and Prediction

A Clustered Optimal ROC Curve Method for Family-Based Genetic Risk Prediction

Multifactorial disease risk calculator: Risk prediction for multifactorial disease pedigrees

PanelPRO: A R package for multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer

Decision Curve Analysis: a Technical Note

Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial.

A Probabilistic Model to Predict Clinical Phenotypic Traits from Genome Sequencing

Leveraging Effect Size Distributions to Improve Polygenic Risk Scores Derived from Summary Statistics of Genome-Wide Association Studies.

PRSice-2: Polygenic Risk Score software for biobank-scale data

Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO

CRPMKB: a Knowledge Base of Cancer Risk Prediction Models for Systematic Comparison and Personalized Applications.

GAPIT: genome association and prediction integrated tool.

Supplementary Table S4 from Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes

Integrative genetic risk prediction using nonparametric empirical Bayes classification

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models